Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $21.39 $25.74 Friday, 10th May 2024 ARWR stock ended at $22.08. This is 10.68% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 16.93% from a day low at $21.79 to a day high of $25.48.
90 days $21.39 $36.72
52 weeks $20.67 $40.89

Historical Arrowhead Research Corporation prices

Date Open High Low Close Volume
Mar 01, 2023 $32.45 $32.84 $32.40 $32.66 1 125 980
Feb 28, 2023 $32.45 $33.12 $32.28 $32.30 924 508
Feb 27, 2023 $33.05 $33.17 $32.34 $32.60 682 301
Feb 24, 2023 $32.10 $32.85 $32.10 $32.63 866 001
Feb 23, 2023 $32.90 $33.07 $32.52 $32.75 665 204
Feb 22, 2023 $31.83 $32.95 $31.78 $32.85 772 404
Feb 21, 2023 $33.00 $33.28 $31.29 $31.77 897 529
Feb 17, 2023 $33.07 $33.86 $32.50 $33.75 584 136
Feb 16, 2023 $33.36 $33.80 $32.94 $32.97 615 584
Feb 15, 2023 $33.23 $34.08 $32.76 $34.05 626 675
Feb 14, 2023 $34.48 $35.15 $33.46 $33.67 868 995
Feb 13, 2023 $33.24 $34.75 $32.78 $34.60 687 983
Feb 10, 2023 $32.99 $33.42 $32.48 $33.12 814 725
Feb 09, 2023 $32.98 $34.08 $32.50 $33.16 737 208
Feb 08, 2023 $33.32 $33.92 $32.37 $32.58 816 912
Feb 07, 2023 $33.54 $34.24 $32.06 $33.62 1 529 579
Feb 06, 2023 $35.37 $35.99 $32.23 $33.51 1 647 485
Feb 03, 2023 $36.36 $37.71 $36.23 $36.74 611 328
Feb 02, 2023 $35.75 $37.01 $35.47 $37.01 726 080
Feb 01, 2023 $34.85 $35.88 $34.27 $35.29 767 956
Jan 31, 2023 $33.51 $35.03 $33.51 $34.99 854 449
Jan 30, 2023 $33.20 $33.80 $32.89 $33.28 807 921
Jan 27, 2023 $33.29 $34.08 $33.21 $33.61 427 156
Jan 26, 2023 $33.24 $33.76 $32.60 $33.28 591 938
Jan 25, 2023 $33.44 $33.82 $32.22 $32.97 756 175
Click to get the best stock tips daily for free!

About Arrowhead Research Corporation

Arrowhead Research Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase 3 clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in P... ARWR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT